Lumenis, the inventors of Intense Pulsed Light (IPL), now offers clinicians the advanced Optima IPL.
With every pulse of light, this energy-based therapy works to control the inflammatory process, to stop the vicious cycle of dry eye due to meibomian gland dysfunction, displacing drops and drugs and providing long-lasting results. With no ongoing consumable costs and clinically proven outcomes, the Optima IPL offers exceptional value to clinicians looking to ‘up their dry eye game’ in 2020.
Contact: Lumenis (AUS) 1800 586 364